Patent 7687662 was granted and assigned to Millennium Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.